⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 28, 2026American Journal of Respiratory and Critical Care MedicineOpen Access

Towards an optimized framework for human dose prediction in anti-tuberculosis drug development

Anu Patel Angela T. Li Belén P. Solans Radojka M. Savić

View Full Paper

Ask AI

Bookmark

Share

Abstract

Anu Patel, Angela T Li, Belén P Solans, Radojka M Savic; Towards an optimized framework for human dose prediction in anti-tuberculosis drug development, Am

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Patel et al. (2026) studied this question.

synapsesocial.com/papers/6ae5857e4c46c197bbab443a https://doi.org/10.1093/ajrccm/aamag580

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pharmacological Principles in the Use and Development of Antituberculosis DrugsOriginal Research · 2026
2Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with TuberculosisOriginal Research · 2026
3Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationReview · 2026
4Computational Design and Evaluation of N-Aryl Oxamic Acid Derivatives Targeting Mycobacterium Tuberculosis Protein Tyrosine Phosphatase B (PtpB): 2D-QSAR, Molecular docking, MD Simulations, DFT, and Pharmacokinetic Profiling2025
5Computational drug screening for drug-resistant tuberculosis: advances, challenges, and future perspectivesReview · 2026

Rapid, accurate, and reproducible <i>de novo</i> prediction of resistance to antituberculars2025
Model‐Informed Approaches to Optimizing Therapeutics in the African Patient Populations2024
Computational approaches: Atom-based 3D-QSAR, molecular docking, ADME-Tox, MD simulation and DFT to find novel multi-targeted Anti-tubercular agents2024
Reversal of nasal epithelial permeability in severe eosinophilic asthma by anti-IL5Rα antibody, benralizumabAmerican Journal of Respiratory and Critical Care Medicine · 2026
The Future of AI in Critical Care: An Exploration in Ten ParablesAmerican Journal of Respiratory and Critical Care Medicine · 2026

More from American Journal of Respiratory and Critical Care Medicine

More from University of California, Berkeley

More from University of California, San Francisco